187 related articles for article (PubMed ID: 37351346)
1. The impact of NKG2A and NKG2D receptors and HLA-E and MICA ligands polymorphisms on post-transplant complications after paediatric allogeneic HSCT: a single-centre experience.
Siemaszko J; Ussowicz M; Rybka B; Ryczan-Krawczyk R; Kałwak K; Bogunia-Kubik K
Front Genet; 2023; 14():1186123. PubMed ID: 37351346
[No Abstract] [Full Text] [Related]
2. Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells.
Siemaszko J; Łacina P; Szymczak D; Szeremet A; Majcherek M; Czyż A; Sobczyk-Kruszelnicka M; Fidyk W; Solarska I; Nasiłowska-Adamska B; Skowrońska P; Bieniaszewska M; Tomaszewska A; Basak GW; Giebel S; Wróbel T; Bogunia-Kubik K
Front Immunol; 2023; 14():1227897. PubMed ID: 37901227
[TBL] [Abstract][Full Text] [Related]
3. The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients.
Rohn H; Tomoya Michita R; Schwich E; Dolff S; Gäckler A; Trilling M; Le-Trilling VTK; Wilde B; Korth J; Heinemann FM; Horn PA; Kribben A; Witzke O; Rebmann V
Front Immunol; 2018; 9():917. PubMed ID: 29867932
[TBL] [Abstract][Full Text] [Related]
4. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
Wetzel L; Wittig S; Gruhn B
J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
[TBL] [Abstract][Full Text] [Related]
5. Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation.
Machuldova A; Holubova M; Caputo VS; Cedikova M; Jindra P; Houdova L; Pitule P
Front Immunol; 2021; 12():651751. PubMed ID: 33868289
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts.
Picardi A; Mengarelli A; Marino M; Gallo E; Benevolo M; Pescarmona E; Cocco R; Fraioli R; Tremante E; Petti MC; De Fabritiis P; Giacomini P
J Exp Clin Cancer Res; 2015 Sep; 34(1):98. PubMed ID: 26361968
[TBL] [Abstract][Full Text] [Related]
7. Impact of donor NKG2D and MICA gene polymorphism on clinical outcomes of adult and paediatric allogeneic cord blood transplantation for malignant diseases.
Cox ST; Patterson W; Duggleby R; Jones OJR; Madrigal JA; Querol S; Salvador FR; Mata MJH; Volt F; Gluckman É; Szydlo R; Danby RD; Hernandez D
Eur J Haematol; 2024 Jul; 113(1):32-43. PubMed ID: 38511389
[TBL] [Abstract][Full Text] [Related]
8. Single-Nucleotide Polymorphisms in MICA and MICB Genes Could Play a Role in the Outcome in AML Patients after HSCT.
Machuldova A; Houdova L; Kratochvilova K; Leba M; Jindra P; Ostasov P; Maceckova D; Klieber R; Gmucova H; Sramek J; Holubova M
J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682758
[TBL] [Abstract][Full Text] [Related]
9. Shared epitope and polymorphism of
Wielińska J; Tarassi K; Iwaszko M; Kościńska K; Wysoczańska B; Mole E; Kitsiou V; Świerkot J; Kolossa K; Kouniaki D; Athanassiades T; Tsirogianni A; Bogunia-Kubik K
Cent Eur J Immunol; 2021; 46(1):92-98. PubMed ID: 33897289
[TBL] [Abstract][Full Text] [Related]
10. Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation.
Patel SS; Rybicki LA; Yurch M; Thomas D; Liu H; Dean R; Jagadeesh D; Hill B; Pohlman B; Bolwell B; Hanna R; Hamilton BK; Kalaycio M; Gerds AT; Cober E; Mossad S; Zhang A; Majhail NS; Askar M; Sobecks R
Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):32-39. PubMed ID: 31881183
[TBL] [Abstract][Full Text] [Related]
11. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
[TBL] [Abstract][Full Text] [Related]
12. Donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after HLA-matched hematopoietic stem-cell transplantation: HLA-C allotype is an essential cofactor.
Behrendt CE; Nakamura R; Forman SJ; Zaia JA
Front Immunol; 2013; 4():36. PubMed ID: 23440333
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
14. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
15. Relapse Protection Following Early Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation Is Limited to HLA-C Killer Cell Immunoglobulin-Like Receptor Ligand Homozygous Recipients.
Nikoloudis A; Wagner H; Machherndl-Spandl S; Buxhofer-Ausch V; Strassl I; Stiefel O; Wipplinger D; Milanov R; Kaynak E; Hasengruber P; Binder M; Weltermann A; Petzer A; Wolf D; Nachbaur D; Clausen J
Transplant Cell Ther; 2021 Aug; 27(8):686.e1-686.e9. PubMed ID: 33991724
[TBL] [Abstract][Full Text] [Related]
16. Effect of Donor NKG2D Polymorphism on Relapse after Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
Ido K; Koh H; Hirose A; Seto T; Makuuchi Y; Kuno M; Takakuwa T; Okamura H; Nanno S; Nakamae M; Nishimoto M; Nakashima Y; Hino M; Nakamae H
Transplant Cell Ther; 2022 Jan; 28(1):20.e1-20.e10. PubMed ID: 34607074
[TBL] [Abstract][Full Text] [Related]
17. Decreased Soluble Human Leukocyte Antigen E Levels in Patients After Allogeneic Hematopoietic Stem Cell Transplantation Are Associated With Severe Acute and Extended Chronic Graft-versus-Host Disease and Inferior Overall Survival.
Kordelas L; Schwich E; Lindemann M; Heinemann FM; Buttkereit U; Horn PA; Beelen DW; Rebmann V
Front Immunol; 2019; 10():3027. PubMed ID: 31998310
[TBL] [Abstract][Full Text] [Related]
18. Quantity and Quality Reconstitution of NKG2A
Hu LJ; Zhao XY; Yu XX; Lv M; Han TT; Han W; Huang XJ
Biol Blood Marrow Transplant; 2019 Jan; 25(1):1-11. PubMed ID: 30142416
[TBL] [Abstract][Full Text] [Related]
19. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
20. The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation.
Zuo W; Yu XX; Liu XF; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Zhao XS; Huang XJ; Zhao XY
Front Immunol; 2022; 13():814334. PubMed ID: 35572602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]